Orari di ricevimento
lun e merc 12-13
Curriculum
BIOGRAPHICAL
Date of Birth: November 10, 1960
Place: Rome, Italy
Home Address: Via del Babuino 46
00187 Rome - IT
Tel: +39 348 339-2006
Email: f.pelliccia@mclink.it
BOARD CERTIFICATION
12/01/2004 European Cardiologist Diploma by the European Board for the Specialty of Cardiology (EBSC)
07/18/1989 Italian Board Cardiology Certification
PRESENT POSITION
06/2011 – present Professor of Cardiology,
Attending Cardiologist,
Division of Cardiology, Interventional Cardiology Unit,
‘Sapienza’ University School of Medicine
Rome, Italy
EDUCATION
03/2005 – 03/2008 Philosophiae Doctor (Ph.D.) in Cardiovascular Sciences
Department of Cardiovascular and Neurological Sciences
University School of Medicine,
Cagliari, Italy
01/1991 − 01/1993 Internal Medicine and Surgery training courses
Lazio Region Medical School Hospitals,
Rome, Italy
11/1986 − 07/1989 Cardiology fellowship
Department of Cardiovascular and Respiratory Sciences
Hospital Umberto I
‘Sapienza’ University of Rome, School of Medicine,
Rome, Italy
11/1985 – 11/1986 Internal Medicine internship-residencies
Hospital Umberto I
‘ Sapienza’ University of Rome, School of Medicine,
Rome, Italy
10/1982 – 10/1985 Medical Student
‘Sapienza’ University of Rome, School of Medicine,
Rome, Italy
LICENSURE INFORMATION
02/01/1986 Italy – Full License to Practice Medicine No. 37183
PROFESSIONAL WORK HISTORY AND TEACHING EXPERIENCE
2012 Visiting Scientist
Columbia University
Presbiterian Hospital
New York, New York, US
2006-… Professor of Specialty Course in Cardiology
‘Sapienza’ University of Rome, School of Medicine,
Rome, Italy
2005-2008 Supervisor of Medical Students and Fellows of the Specialty Course in Cardiology
University of Caglari, Cagliari, Italy
2003-2010 Attending Cardiologist
Department of Cardiology,
San Filippo Neri Hospital,
Rome, Italy
2001-2002 Attending Cardiologist
Department of Cardiology,
San Camillo Hospital,
Rome, Italy
1995-2000 Clinician-Educator and Medical Director-1st level
Cardio-Thoracic and Vascular Department
San Raffaele Vita Salute University, Rome-Milan, Italy
1990-1993 Visiting Scientist
University of Bologna, Medical School,
Department of Cardiology
Bologna, Italy
1989 Visiting Scientist
St. George’s Hospital Medical School
Department of Cardiological Sciences
London, UK
Invasive Procedures Workload
Procedure type Number of interventional cases
Percutaneous coronary intervention N=2.500 (80% transradial)
PFO closure N=100
LAA closure N=25
Renal denervation N=50
MEMBERSHIP IN SOCIETIES/PROFESSIONAL ORGANIZATIONS
1999- present Fellow, American College of Cardiology (F.A.C.C.)
2003- present Fellow, European Society of Cardiology (F.E.S.C.)
HONORS
2009
2004
TCT Top Paper Prize (best research contribution)
Cardiovascular Research Foundation
Elected European Cardiologist by the European Board for the Specialty of Cardiology (EBSC)
1989
1989 Giornate Cardiologiche Romane Prize
(best research manuscript)
Summa cum laude Cardiology Specialty
‘Sapienza’ University, School of Medicine
Rome, Italy
1987 Luigi Condorelli Annual Prize
(best research manuscript by cardiology specialists)
‘Sapienza’ University, School of Medicine
Rome, Italy
1986
1985
1985 Lions Club Prize
(best scientific manuscript)
Italian Society of Cardiology Prize
(best scientific contribution)
Medical Doctor (M.D.) summa cum laude
‘Sapienza’ University, School of Medicine
Rome, Italy
ADDITIONAL INFORMATION
Organizing Committes
2001-2011 Coordinator of the Scientific Committee of the Annual Meeting of the Department of Cardiology of the University of Cagliari, Cagliari, Italy
2004-2005 Chairman of the Consensus Panel SIC-ANMCO on ‘Chest Pain Unit
2006-2008 Member of the Committee on ‘Low risk chest pain’ of the Lazio Region in cooperation with SIC and ANMCO
2008-2010 Chairman of the Expert Panel of the International Society of Cardiovascular Ultrasound (ISCU) on training requirements for non-cardiologists using hand-carried ultrasound devices
Journal Reviewer for:
Heart and Vessel (since 2000)
American Journal of Cardiology (since 2003)
Drugs (since 2006)
Lancet (since 2007)
Yonsei Medical Journal (since 2007)
American Heart Journal (since 2007)
Recent Patents on Cardiovascular Drug Discovery (since 2009)
BMJ Case Reports (since 2010)
International Journal of Cardiology (since 2011)
Archives of Medical Research (since 2012)
PlosONE (since 2013)
AREA OF RESEARCH
Coronary artery disease
Interventional cardiology
Pharmacology
Cardiomyopathy
FUNDING INFORMATION
Trial ATPCI – Principal Investigator (2013)
Trial RIVER – Principal Investigator (2012)
PREVAIL Registry – Investigator (2010)
Euro Heart Survey – Investigator (2005)
Trial Armyda – Investigator (since 2004)
INVITED LECTURES AT SYMPOSIA AND CONFERENCES
“Miocardiopatia idiopàtica dilatada: Es la funcion ventricular un predictor de la muerte en la ICC?”.
International Symposium: “Symposium Internacional sobre Insuficiencia Cardiaca Cronica - Diagnostico Y Trattamento”,
Bilbao, Spain, March 22-24, 1990
“Myocardial hypertrophy in advanced age”.
International Symposium: “International Symposium on Myocardial Hypertrophy and Hypertrophic Cardiomyopathy”,
Parma, Italy, 10-11 June 10-11, 1994
"The role of continuous ECG monitoring"
European Heart House Intramural Course: "Risk stratification and management of patients with acute chest pain: The role of "Chest Pain Units"
Sophia Antipolis, France, May 22-24, 1999
"The outreach program: Education of the public to promptly seek medical care; The attack program: How to minimise delays in triage of chest pain patients".
European Heart House Intramural Course: "Risk stratification and management of patients with acute chest pain: The role of "Chest Pain Units"
Sophia Antipolis, France, May 22-24, 1999
“Secondary Prevention: Smoking, Exercise and Stress".
European Heart House Intramural Course: "Office-Based Coronary Artery Disease Prevention"
Sophia Antipolis, France, May 10-12, 2000
“Lo studio dell’ipertrofia ventricolare in modelli clinici particolari – L’atleta”
Corso Intramurale della Società Italiana di Cardiologia: “Ipertrofia ventricolare sinistra”
Roma, 1-2 dicembre 2000, 16-17 marzo 2001
“Lo studio dell’ipertrofia ventricolare in modelli clinici particolari – L’atleta”
Corso Intramurale della Società Italiana di Cardiologia: “Ipertrofia ventricolare sinistra”
Roma, 1-2 dicembre 2000, 20-21 maggio 2001.
“The six components of Chest Pain Units, The outreach program: Education of the public to promptly seek medical care”
European Heart House Extramural Course: “The role of Chest Pain Units in Risk Stratification and Management of Patients with Chest Pain”,
Roma, Italy, June 14-16, 2001
“Secondary Prevention: Smoking, Exercise and Stress"
European Heart House Extramural Course: "Office-Based Coronary Artery Disease Prevention"
Roma, Italy, June 16-18, 2002.
“Lo studio dell’ipertrofia ventricolare in modelli clinici particolari – L’atleta”
Corso Intramurale della Società Italiana di Cardiologia: “Ipertrofia ventricolare sinistra”
Roma, 1-2 dicembre 2000, October 18-19, 2002.
“Il background filosofico delle CPU”
Corso Extra-murale ANMCO: “La ‘Chest Pain Unit’: La soluzione ideale per la gestione ospedaliera del dolore toracico”
Roma, Italy, October 24-25, 2003
“Evaluation of chest pain: The role of echocardiography”.
International Society Cardiovascular Ultrasound – Italian Chapter Annual Meeting
Bari, June 1-3, 2007
“Il difficile compromesso tra la pratica clinica e le linee guida nella gestione del paziente con cardiopatia ischemica”.
6° Congresso Nazionale della Società Mediterranea di Medicina dello Sport,
Trapani, 21-24 giugno 2007
“Interventional Echocardiography. The role of cardiovascular ultrasounds in the cath lab”
International Society Cardiovascular Ultrasound – Italian Chapter Annual Meeting
Napoli, May 15-17, 2008
“Ruolo delle EPC nella re-stenosi coronarica post-angioplastica”
69° Congresso Nazionale della S.I.C. (Società Italiana di Cardiologia)
Roma, 13-16 dicembre 2008
“Diseases of the aortic valve: sclerosis and stenosis – Diagnosis and treatment”
International Society Cardiovascular Ultrasound – Italian Chapter Annual Meeting
Ostuni, Italy, May 14, 2009
“Hupertrophic cardiomyopathy”
International Society Cardiovascular Ultrasound – Italian Chapter Annual Meeting
Rome, Italy, May 15, 2010
“Cardiovascular Diseases in Multiethnicity”
1st International Congress GREAT Network ‘Focus on innovations and research in emergency medicine’
Rome, Italy, October 20, 2010
“Left Atrial Appendage Closure”
14th International Congress ‘Cardiac Pacing’
Rome, Italy, December 4, 2010
“The different pharmacological response in the cardiovascular diseases in the different ethnic groups”
2nd International Congress GREAT Network ‘Focus on innovations and research in emergency medicine’
Rome, Italy, October 20, 2011
“Stable Ischemic Heart Disease – Medical Therapy & Percutaneous Coronary Intervention”
2011 Chronic Angina Meeting
Orlando, Florida (USA), November 13, 2011
“Therapeutic benefits of the newer anti-anginal treatments”
Round Table ‘Chronic stable angina guidelines – is there an emerging International consensus?’
Royal Society, London, January 27, 2012
“Percutaneous treatment of aortic valve disease”
International Society Cardiovascular Ultrasound – Italian Chapter Annual Meeting
Ostuni, May 15-17, 2012
“Which is the best treatment for stable angina pectoris: cardiologists point of view”
3rd International Congress GREAT Network ‘Focus on innovations and research in emergency medicine’
Rome, Italy, October 17, 2012
“Reducing peri-procedural ischaemic injury: what are the options?”
Euro PCR
22 Maggio 2013, Parigi, Francia
26, “Current evidence and future perspectives on n-3 PUFA”
ESC Working Group New Trends in Cardiovascular Drug Therapy –
7- 8 June 2013, Rome, Italy
27.“Hypertension: Should we ablate all hypertensives?”
ESC Working Group New Trends in Cardiovascular Drug Therapy –
7 – 8 June 2013, Rome, Italy
28. “Cardioprotection with antidiabetic drugs. Myth or reality?”
18th Annual Scientific Meeting of the International Society of Cardiovascular Pharmacotherapy –
28-30 June 2013, Rome, Italy
29. “Ranolazine: rationale, current data on residual post PCI angina and ongoing trials” -
IV INTERNATIONAL ACS CROSSROADS
18/19 Ottobre 2013, Baveno, Italia
30. “The antianginal, antiischemic and cardioprotective effects of ranolazine”
International Ranolazine Medical Experts Meeting
6-7 December 2013, Berlino, Germania
31. “Attuali evidenze scientifiche e prospettive future della terapia con PUFA n-3”
74° Congresso Nazionale della S.I.C. (Società Italiana di Cardiologia)
Roma, 14-16 dicembre 2013
32 “Therapeutic benefits of eplerenone”
Round Table ‘The safety and efficacy of eplerenone in mild-to-moderate essential hypertension?’
Royal Society, London, March 1, 2014
33. “New Oral Anticoagulants: From real life to scientific guidelines and back”
18th Annual Scientific Meeting of the International Society of Cardiovascular Pharmacotherapy
28 March, 2014, Paris, France
SCIENTIFIC STATUS (source: Scopus, as May 1, 2014)
Total articles: 97
Overall citations: 717
Hirsch index (h). 12
ARTICLES IN PEER-REVIEWED JOURNALS
1. F. Romeo, Pelliccia F, C. Cianfrocca, R. Cristofani, A. Reale: Predictors of sudden death in idiopathic dilated cardiomyopathy. Am J Cardiol 1989; 63: 138-140. (Impact Factor: 3,059)
2. F. Romeo, Pelliccia F, C. Cianfrocca, P. Gallo, F. Barillà, R. Cristofani, A. Reale: Determinants of end-stage idiopathic dilated cardiomyopathy: a multivariate analysis of 104 patients. Clin Cardiol 1989; 12: 387-392. (Impact Factor: 1,108)
3. F. Barillà, Pelliccia F, A. Valente, C. Cianfrocca, F. Romeo, A. Reale: Acute effects of nifedipine vs isosorbide dinitrate in patients with isolated coronary occlusion and collaterals. Cardiovasc Drugs Ther, 1990; 4 (Suppl. 5): 905-908. (Impact Factor: 1,624)
4. F. Romeo, Pelliccia F, R. Cristofani, E. Martuscelli, A. Reale: Hypertrophic cardiomyopathy: Is a left ventricular outflow tract gradient a major prognostic determinant? Eur Heart J, 1990; 11: 233-240. (Impact Factor: 7,341)
5. Pelliccia F, C. Cianfrocca, F. Romeo: The progression of hypertrophic cardiomyopathy: dilatation of the left ventricle with supernormal systolic function. Int J Cardiol, 1990; 26: 232-234. (Impact Factor: 6.802)
6. Pelliccia F, C. Cianfrocca, R. Cristofani, F. Romeo, A. Reale: Electrocardiographic findings in patients with hypertrophic cardiomyopathy. Relation to presenting features and prognosis. J Electrocardiol, 1990; 23 (3): 213-222. (Impact Factor: 0,852)
7. F. Romeo, C. Cianfrocca, Pelliccia F, V. Colloridi, R. Cristofani, A. Reale: Long-term prognosis in children with hypertrophic cardiomyopathy: An analysis of 37 patients aged<14 years at diagnosis. Clin Cardiol, 1990; 13: 101-107. (Impact Factor: 1,108)
8. Pelliccia F, P. Gallo, C. Cianfrocca, G. d'Amati, P. Bernucci, A. Reale: Relation of complex ventricular arrhythmias to presenting features and prognosis in dilated cardiomyopathy. Int J Cardiol, 1990; 29: 47-54. (Impact Factor: 6.802)
9. Pelliccia F, C. Cianfrocca, F. Romeo, A. Reale: Hypertrophic cardiomyopathy: Long-term effects of propranolol versus verapamil in preventing sudden death in 'low-risk' patients. Cardiovasc Drugs Ther, 1990; 4: 1515-1518. (Impact Factor: 1,624)
10. Pelliccia F, C. Cianfrocca, F. Romeo, A. Reale: Natural history of hypertrophic cardiomyopathy in the elderly. Cardiology, 1991; 78: 329-333. (Impact Factor: 2,092)
11. Pelliccia F, G. Critelli, C. Cianfrocca, A. Nigri, A. Reale: Electrocardiographic correlates with left ventricular morphology in idiopathic dilated cardiomyopathy. Am J Cardiol, 1991; 68: 642-647. (Impact Factor: 3,059)
12. Pelliccia F, C. Cianfrocca, C. Gaudio, A. Reale: Sudden death during pregnancy in hypertrophic cardiomyopathy. Eur Heart J, 1992; 13: 421-423. (Impact Factor: 7,341)
13. C. Gaudio, Pelliccia F, G. Tanzilli, P. Mazzarotto, C. Cianfrocca, B. Marino: Magnetic resonance imaging for assessment of apical hypertrophy in hypertrophic cardiomyopathy. Clin Cardiol, 1992; 15: 164-168. (Impact Factor: 1,108)
14. P. Gallo, G. d'Amati, Pelliccia F: Pathologic evidence of extensive left ventricular involvement in arrhythmogenic right ventricular cardiomyopathy. Hum Pathol, 1992; 23: 948-952. (Impact Factor: 2,550)
15. C. Cianfrocca, Pelliccia F, A. Nigri, G. Critelli: Resting and ambulatory electrocardiographic predictors of mode of death in dilated cardiomyopathy. J Electrocardiol 1992; 25: 295-303. (Impact Factor: 0,852)
16. Pelliccia F, G. Critelli: Evidence for a prognostic role of the JT interval (readers’ comments). Am J Cardiol, 1993; 71: 758. (Impact Factor: 3,059)
17. Pelliccia F, A. Borghi, A. Ruggeri, C. Cianfrocca, G. L. Morgagni, R. Bugiardini: Changes in pulmonary hemodynamics predict benefits in exercise capacity after ACE-inhibition in patients with mild to moderate congestive heart failure. Clin Cardiol, 1993; 16: 607-612. (Impact Factor: 1,108)
18. Pelliccia F, G. d'Amati, C. Cianfrocca, P. Bernucci, A. Nigri, B. Marino, P Gallo: Histomorphometric features predict 1-year outcome of patients with idiopathic dilated cardiomyopathy considered to be at low priority for cardiac transplantation. Am Heart J, 1994; 128: 316-325. (Impact Factor: 3,552)
19. S. De Castro, Pelliccia F, D. Cartoni, S. Funaro, G. Melillo, S. Beni, G. Magni, G. Migliau, F. Fedele: Effects of angiotensin converting enzyme inhibition on left ventricular geometric pattern in patients with essential hypertension. J Clin Pharmacol 1996; 34: 1141-1148. (Impact Factor: 2,889)
20. G.M.C. Rosano, F. Leonardo, P. Pagnotta, Pelliccia F, G. Panina, E. Cerquetani, P. Lilla della Monica, B. Bonfigli, M. Volpe, S.L. Chierchia. Acute effects of testosterone in patients with coronary artery disease. Circulation 1999; 99: 1666-1670 (Impact Factor: 11,632)
21. Pelliccia F, C. Cianfrocca, G. Marazzi, M. Pagliei, M. Mariani, G.M.C. Rosano. Continuous 12-lead ST-segment monitoring improves identification of “low-risk” chest pain patients with a worse in-hospital outcome. Clin Cardiol 2002; 25: 57-62. (Impact Factor: 1,108)
22. Pelliccia F, D. Cartoni, M. Verde, P. Salvini, S. Petrolati, G. Mercuro, P. Tanzi. Comparison of presenting features, diagnostic tools, hospital outcomes, and quality of care indicators in older (> 65 years) to younger, men to women, and diabetics to nondiabetics with acute chest pain triaged in the emergency department. Am J Cardiol 2004; 94: 216-219. (Impact Factor: 3,059)
23. Pelliccia F, D. Cartoni, M. Verde, P. Salvini, G. Mercuro, P. Tanzi. Critical pathways in the emergency department improve treatment modalities for patients with ST-elevation myocardial infarction in a European hospital. Clin Cardiol 2004; 27: 698-700. (Impact Factor: 1,108)
24. V. Pasceri, C. Pristipino, F. PELLICCIA, A. Granatelli, G. Speciale, A. Roncella, B. Pironi, M. Papasso, G. Richichi. Effects of the nitric oxide donor nitroprusside on no-reflow phenomenon during coronary interventions for acute myocardial infarction. Am J Cardiol 2005; 95: 1358-1361. (Impact Factor: 3,059)
25. C. Pristipino, A. Granatelli, M. Capasso, V. Pasceri, Pelliccia F, G. Orvieto, F. D’Errico, B. Pironi, G. Richichi. Effects of reperfusion obtained two to six months after acute myocardial infarction on myocardial electrical stabilization in patients with an occluded infarct-related coronary artery. Am J Cardiol 2005; 96: 769-772. (Impact Factor: 3,059)
26. Pelliccia F, Salvini P, Cartoni D, Polletta B, Pasceri V, Pristipino C, Richichi G, Mercuro G, Tanzi P. Frequency and clinical correlates of changes in Thrombolysis In Myocardial Infarction risk score during observation period at emergency department in "low-risk" patients with acute chest pain.. Am J Cardiol 2006; 97: 781-784. (Impact Factor: 3,059)
27. V. Pasceri, Pelliccia F, C. Cianfrocca, C. Pristipino, M. Santini, G. Richichi. Very late thrombosis after sirolimus-eluting stent implantation. J Cardiovasc Med 2006; 7: 438-42 (Impact Factor: 0.786)
28. Pelliccia F, V. Pasceri, A. Granatelli, C. Pristipino, G. Speciale, A. Roncella, C. Cianfrocca, G. Mercuro, G. Richichi. Safety and efficacy of short-term celecoxib before elective percutaneous coronary intervention for stable angina pectoris. Am J Cardiol 2006; 98: 1461-3. (Impact Factor: 3,059)
29. G. Marazzi, M. Wajngarten, C. Vitale, R. Patrizi, Pelliccia F, O. Gebara, H. Pierri, J.A. Ramires, M. Volterrani, M. Fini, G.M. Rosano. Effect of free fatty acid inhibition on silent and symptomatic myocardial ischemia in diabetic patients with coronary artery disease. Int J Cardiol 2006; Nov 27. (Impact Factor: 6.802)
30. Pelliccia F, C. Cianfrocca, C. Pristipino, V. Pasceri, A. Auriti, G. Richichi, E. Mangieri, C. Gaudio. Cumulative exercise-induced left ventricular systolic and diastolic dysfunction in hypertrophic cardiomyopathy. Int J Cardiol 2006; Dec 28. (Impact Factor: 6.802)
31. C. Pristipino, Pelliccia F, A. Granatelli, V. Pasceri, A. Roncella, G. Speciale, T. Hassan, G. Richichi. Comparison of access-related bleeding complications in women versus men undergoing percutaneous coronary catheterization using the radial versus femoral artery. Am J Cardiol 2007; 99: 1216-1221. (Impact Factor: 3,059)
32. Auriti A, Pristipino C, Cianfrocca C, Granatelli A, Guido V, Pelliccia F, Greco S, Richichi G, Santini M. Distal left circumflex coronary artery flow reserve recorded by transthoracic Doppler echocardiography: a comparison with Doppler-wire. Cardiovasc Ultrasound 2007; 5: 22. (Impact Factor: 1.56).
33. C. Cianfrocca, Pelliccia F, A. Auriti, V. Pasceri, Xue Li, G. Richichi, G. Mercuro, M. Santini. Levosimendan allows detection of contractile reserve in patients with chronic ischaemic left ventricular dysfunction and nondiagnostic dobutamine echocardiography. Eur J Heart Fail 2007; 9: 897-900 (Impact Factor: 3,546)
34. Pelliccia F, V. Pasceri. Coronary restenosis: a new strategy for the future? Lancet 2007; 370: 541-542. (Impact Factor: 23,878)
35. E. Mangieri, G. Tanzilli, C. Greco, Pelliccia F, P.E. Puddu, M.C. Acconcia, V. Paravati, C. Gaudio. Clinical results of two-year dual antiplatelet therapy after primary percutaneous coronary intervention with paclitaxel-eluting stents: A single center study. EuroIntervention 2007; 2:222-7. (Impact Factor: 3.285)
36. C. Vitale, G. Mercuro, E. Cerquetani, G. Marazzi, R. Patrizi, Pelliccia F, M. Volterrani, M. Fini, P. Collins, G. Rosano. Time since menopause influences the acute and chronic effect of estrogens on endothelial function. Arterioscler Thromb Vasc Biol 2008; 28: 348-52 (Impact Factor: 7,432)
37. C. Cianfrocca, Pelliccia F, V. Pasceri, A. Auriti, G. Mercuro, M. Santini. Strain rate analysis and levosimendan improve detection of myocardial viability by dobutamine echocardiography in patients with post-infarction left ventricular dysfunction: a pilot study. J Am Soc Echocardiogr 2008; 21: 1068-74 (Impact Factor: 1,513)
38. C. Gaudio, F. Mirabelli, Pelliccia F, M. Francone, G. Tanzilli, S. Di Michele, S. Leonetti, G. De Vincentis, I. Carbone, E. Mangieri, C. Catalano, R. Passariello. Early detection of coronary artery disease by 64-slice multidetector computed tomography in asymptomatic hypertensive high-risk patients. Int J Cardiol 2008; 135: 280-286. (Impact Factor: 6.802)
39. Pelliccia F, C. Cianfrocca, V. Pasceri, A. Granatelli, G. Speciale, A. Roncella, M. Turturo, G. Richichi, C. Pristipino. Transcathether occlusion of interatrial communications postprocedural transesophageal echocardiography allows timely detection and treatment of intracardiac thrombus formation. Eur J Echocardiogr 2009; 10: 439-441 (Impact Factor: 2,000)
40. Pelliccia F, V. Pasceri, G. Meoni, C. Pristipino, C. Cianfrocca, X. Li, S. La Rocca, G. Rosano, G. Mercuro, G. Richichi. Numbers of endothelial progenitor cells in peripheral blood are similar in younger and older patients with coronary artery disease. Int J Cardiol 2009; 33: 277-279 (Impact Factor: 6.802)
41. C. Cianfrocca, Pelliccia F, C-reactive protein and left atrial appendage velocity are independent determinants of the risk of thrombogenesis in patients with atrial fibrillation. Int J Cardiol 2009; (Impact Factor: 6.802)
42. Pelliccia F, V. Pasceri, C. Cianfrocca, C. Vitale, C. Pristipino, G. Speciale, G. Mercuro, G. Rosano. Endothelial progenitor cells in patients with coronary artery disease and left ventricular dysfunction. Coron Artery Dis 2009; 20: 303-308. (Impact Factor: 1,507)
43. Pelliccia F, V. Pasceri, C. Cianfrocca, C. Vitale, G. Meoni, C. Pristipino, G. Speciale, G. Mercuro, G. Rosano. Circulating endothelial progenitor cells in postmenopausal women with and without coronary artery disease. Climacteric 2009; 12: 259-265. (Impact Factor: 2,275)
44. Tanzilli G, Greco C, Pelliccia F, Pasceri V, Barillà F, Paravati V, Pannitteri G, Gaudio C, Mangieri E. Effectiveness of Two-Year Clopidogrel + Aspirin in Abolishing the Risk of Very Late Thrombosis After Drug-Eluting Stent Implantation (From the TYCOON [Two-Year ClOpidOgrel Need] Study). Am J Cardiol 2009; Am J Cardiol 2009;104: 1357–1361 (Impact Factor: 3,059)
45. Roncella A, Giornetti A, Cianfrocca C, Pasceri V, Pelliccia F, Denollet J, Pedersen SS, Speciale G, Richichi G, Pristipino C. Rationale and trial design of a randomized, controlled study on short-term psychotherapy after acute myocardial infarction: the STEP-IN-AMI trial (Short Term Psychotherapy in Acute Myocardial Infarction). J Cardiovasc Med (Hagerstown) 2009; 10:947-452 (Impact Factor: 0.786)
46. Pelliccia F, Pasceri V, Cianfrocca C, Vitale C, Speciale G, Gaudio C, Rosano GM, Mercuro G. Angiotensin II receptor antagonism with telmisartan increases number of endothelial progenitor cells in normotensive patients with coronary artery disease: A randomized, double-blind, placebo-controlled study. Atherosclerosis 2010; 210; 510-515. (Impact Factor: 0,000)
47. Pasceri V, Patti G, Pristipino C, Pelliccia F, Irini D, Varveri A, Roncella A, Di Sciascio G, Speciale G. Safety of drug eluting stents in patients on chronic anticoagulation using long-term single antiplatelet treatment with clopidogrel. Catheter Cardiovasc Interv 2010; 75: 936-42. (Impact Factor: 2,363)
48. Pelliccia F, Cianfrocca C, Rosano G, Mercuro G, Speciale G, Pasceri V. Role of endothelial progenitor cells in restenosis and progression of coronary atherosclerosis after percutaneous coronary intervention: a prospective study. JACC Cardiovasc Interv 2010; 3: 78-86. (Impact Factor: 0,000)
49. Gaudio C, Evangelista A, Pasceri V, Pannarale G, Varrica S, Romitelli S, Pelliccia F, Pellegrini M. Visualization of coronary arteries and coronary stents by low dose 320-slice multi-detector computed tomography in a patient with atrial fibrillation. Int J Cardiol 2010; Mar 16. (Impact Factor: 6.802)
50. Tanzilli G, Greco C, Pasceri V, Pelliccia F, Arrivi A, Placanica A, Mangieri E. Dipyridamole versus verapamil for treatment of no-reflow during primary angioplasty. Catheter Cardiovasc Interv 2010; 76: 787-793 (Impact Factor: 2,363)
51. Speciale G, Pasceri V, D'Angeli I, Pelliccia F, Irini D, Soldini L, Santini M. Spheric balloon technique for ostial bifurcation lesion treatment. Int J Cardiol 2010; 145: 618-20 (Impact Factor: 6.802)
52. Tanzilli G, Pelliccia F, Pasceri V, Speciale G, Greco C, Arrivi A, Viceconte N, Mangieri E, Gaudio C. Randomized study on provisional stenting with sirolimus-eluting stent vs. bare metal stent for the treatment of true coronary bifurcations: The PROSUMER (PROvisional with sirolimus-eluting vs. bare metal stents in truE bifuRcations) study. Int J Cardiol 2011; 146: 240-1 (Impact Factor: 6.802)
53. Vitale C, Marazzi G, Pelliccia F, Volterrani M, Cerquetani E, Spoletini I, Mercuro G, Bonassi S, Dall'Armi V, Fini M, Rosano GM. Trimetazidine improves exercise performance in patients with peripheral arterial disease. Pharmacol Res 2011; 63: 278-83. (Impact Factor: 4,436)
54. Evangelista A, Pelliccia F, Arrivi A, Gaudio C. 320-slice computed tomography and myocardial bridge. BMJ Case Reports 2011 (Impact Factor: 0,000).
55. Marazzi G, Cacciotti L, Pelliccia F, Iaia L, Volterrani M, Caminiti G, Sposato B, Massaro R, Grieco F, Rosano G. Long-term effects of nutraceuticals (berberine, red yeast rice, policosanol) in elderly hypercholesterolemic patients. Adv Ther 2011;28:1105-13 (Impact Factor: 1.668).
56. Pasceri V, Irini D, Pelliccia F, Pristipino C, Roncella A, Varveri A, Speciale G. Treatment of left main disease with a new dedicated side-branch protection stent. J Cardiovasc Med 2011;12:896-900 (Impact Factor: 0.786)
57. Marazzi G, Iellamo F, Volterrani M, Lombardo M, Pelliccia F, Righi D, Grieco F, Cacciotti L, Iaia L, Caminiti G, Rosano G. Comparison of microlife BP A200 Plus and Omron M6 blood pressure monitors to detect atrial fibrillation in hypertensive patients. Adv Ther 2012;29:64-70 (Impact Factor: 1.668).
58. Strumia E, PELLICCIA F, D’Ambrosio G. Creatine phosphate: Pharmacological and clinical perspectives. Adv Ther 2012; (Impact Factor: 1.668).
59. Pelliccia F, Del Prete G, Del Prete A, Greco C, Gaudio C. Effects of percutaneous coronary intervention and stenting with different drug-eluting coatings and platforms on endothelial damage and inflammation. Int J Cardiol 2012; 56: 242-243. (Impact Factor: 7.078).
60. Pelliccia F, Palmiero P, Maiello M, Losi Maria-Angela on behalf of the Italian Chapter of the International Society of Cardiovascular Ultrasound. Italian Chapter of the International Society of Cardiovascular Ultrasound Expert Consensus Document on training requirements for non-cardiologists using hand-carried ultrasound devices. Echocardiography. 2012 May 29; (Impact Factor: 1.668).
61. Pelliccia F, Pasceri V, Marazzi G, Rosano G, Greco C, Gaudio C. A pilot randomized study of ranolazine for reduction of myocardial damage during elective percutaneous coronary intervention. Am Heart J 2012; 163:1019-23 (Impact Factor: 5,052)
62. Pelliccia F, Trani C, Biondi-Zoccai GG, Nazzaro M, Berni A, Patti G, Patrizi R, Pironi B, Mazzarotto P, Gioffrè G, Speciale G, Pristipino C; Prospective Registry of Vascular Access in Interventions in Lazio Region (prevail) Study Group. Comparison of the Feasibility and Effectiveness of Transradial Coronary Angiography Via Right Versus Left Radial Artery Approaches (from the PREVAIL Study). Am J Cardiol. 2012 May 30. (Impact Factor: 3,059)
63. Gaudio C, Pelliccia F, Evangelista A, Tanzilli G, Paravati V, Pannarale G, Pannitteri G, Barillà F, Greco C, Franzoni F, Speziale G, Pasceri V. 320-row computed tomography coronary angiography vs. conventional coronary angiography in patients with suspected coronary artery disease: A systematic review and meta-analysis. Int J Cardiol. 2013;168(2):1562-4.
64. Gaudio C, Pelliccia F, Evangelista A, Viceconte N, Greco C, Franzoni F, Galetta F, Speziale G, Pelliccia A. Sudden death and physical exercise: timely diagnosis of congenital anomalies of the coronary arteries with the new 320-slide multi-detector computed tomography. Intern Emerg Med 2013; 8 Suppl 1: 35-39
65. Pelliccia F, Pasceri V, Rosano G, Pristipino C, Roncella A, Speciale G, Pannarale G, Schiariti M, Greco C, Gaudio C. Endothelial progenitor cells predict long-term prognosis in patients with stable angina treated with percutaneous coronary intervention - Five-year follow-up of the PROCREATION Study. Circ J 2013; 77: 1728-1735 (Impact Factor: 3,766)
66. Pasceri V, Pelliccia F, Pristipino C, Roncella A, Irini D, Varveri A, Bisciglia A, Speciale G. Clinical effects of routine postdilatation of drug-eluting stents. Catheter Cardiovasc Interv. 2013 May 22 (Impact Factor: 2,290)
67. Greco C, Pelliccia F, Tanzilli G, Tinti MD, Salenzi P, Cicerchia C, Schiariti M, Franzoni F, Speziale G, Gallo P, Gaudio C. Usefulness of local delivery of thrombolytics before thrombectomy in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention (the delivery of thrombolytics before thrombectomy in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention [DISSOLUTION] randomized trial). Am J Cardiol 2013 May 24. (Impact Factor: 3,059)
68. Pelliccia F. Endothelial progenitor cells and long-term prognosis in patients with stable angina treated with percutaneous coronary intervention. Circ J. 2013 Aug 23;77(9):2416. (Impact Factor: 3,766)
69. Baigent, C. , Bhala, N., Emberson, J., Merhi, A., Abramson, S., Arber, N., Baron, J.A., Bombardier, C., Cannon, C., Farkouh, M.E., FitzGerald, G.A., Goss, P., Halls, H., Hawk, E., Hawkey, C., Hennekens, C., Hochberg, M., Holland, L.E., Kearney, P.M., Laine, L., Lanas, A., Lance, P., Laupacis, A., Oates, J., Patrono, C., Schnitzer, T.J., Solomon, S., Tugwell, P., Wilson, K., Wittes, J., Adelowo, O., Aisen, P., Al-Quorain, A., Altman, R., Bakris, G., Baumgartner, H., Bresee, C., Carducci, M., Chang, D.-M., Chou, C.-T., Clegg, D., Cudkowicz, M., Doody, L., Miedany, Y.El., Falandry, C., Farley, J., Ford, L., Garcia-Losa, M., Gonzalez-Ortiz, M., Haghighi, M., Hala, M., Iwama, T., Jajic, Z., Kerr, D., Kim, H.-S., Kohne, C., Koo, B.-K., Martin, B., Meinert, C., Muller, N., Myklebust, G., Neustadt, D., Omdal, R., Ozgocmen, S., Papas, A., Patrignani, P., Pelliccia F, Roy, V., Schlegelmilch, I., Umar, A., Wahlstrom, O., Wollheim, F., Yocum, S., Zhang, X.Y., Hall, E., McGettigan, P., Midgley, R., Moore, R.A., Philipson, R., Curtis, S., Reicin, A., Bond, J., Moore, A., Essex, M., Fabule, J., Morrison, B., Tive, L., Bhala, N., Davies, K., Emberson, J., Halls, H., Holland, L.E., Kearney, P.M., Merhi, A., Patrono, C., Wilson, K., Yau, F. Vascular and upper gastrointestinal effects of non-steroidal anti-inflammatory drugs: Meta-analyses of individual participant data from randomised trials. Lancet 2013; 382; 769-779. (Impact Factor: 39.060)
70. Pelliccia F, Marazzi G. Greco C, Franzoni F, Speziale G, Gaudio C. Current evidence and future perspectives on n-3 PUFAs. Int J Cardiol. 2013;170 (Suppl 1):S3-7. (Impact Factor: 7.078).
71. Pelliccia F. Endothelial progenitor cells and long-term prognosis in patients with stable angina treated with percutaneous coronary intervention--reply. Circ J. 2013;77(9):2416.
72. Roncella A, Pristipino C, Cianfrocca C, Scorza S, Pasceri V, Pelliccia F, Denollet J, Pedersen SS, Speciale G. One-year results of the randomized, controlled, short-term psychotherapy in acute myocardial infarction (STEP-IN-AMI) trial. Int J Cardiol. 2013;170:132-9. (Impact Factor: 7.078).
73. Pelliccia F, Rosano G, Marazzi G, Vitale C, Spoletini I, Franzoni F, Speziale G, Polacco M, Greco C, Gaudio C. Pharmacodynamic Comparison of Pitavastatin Versus Atorvastatin on Platelet Reactivity in Patients With Coronary Artery Disease Treated With Dual Antiplatelet Therapy. Circ J. 2013 Dec 27.
74. Pelliccia F, Rosano G, Marazzi G, Vitale C, Spoletini I, Franzoni F, Speziale G, Polacco M, Greco C, Gaudio C. Pharmacodynamic effects of atorvastatin versus rosuvastatin in coronary artery disease patients with normal platelet reactivity while on dual antiplatelet therapy-The PEARL randomized cross-over study. Eur J Pharmacol. 2014 Jan 17;725C:18-22.
75. Spoletini I, Vitale C, Pelliccia F, Fossati C, Rosano GMC. Androgens and cardiovascular disease in postmenopausal women: a systematic review. Climacteric 2014;